Riskpilot← Back to searchSign inGet full accessBONEPROX AB
ABActiveOrg 5569451882Kungsportsavenyen 21Medical specialists activities · NACE 8622Est. 20131-4 employees
Revenue 2024
SEK 11,8M
-7% vs 2023
EBITDA margin
-2.4%
+87% vs 2023
Equity ratio
3.1%
Financial strength
Net profit 2024
SEK -303K
+87% vs 2023
| Revenue | SEK 11,8M | -7% |
| EBITDA | SEK -284K | +87% |
| Net profit | SEK -303K | +87% |
| Total assets | SEK 6,5M | +208% |
| Equity | SEK 203K | -60% |
| Employees | — | — |
Legal name
BONEPROX AB
Org number
5569451882
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 oktober 2013
Share capital
SEK 72 219
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med Remman, Peder Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att analysera tandröntgen- bilder för att upptäcka benskörhet och därmed förenlig verksamhet.
Address
Kungsportsavenyen 21
Email
peder.remman@boneprox.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1 753 | 831 | 2 360 | 4 726 | 6 487 | 12 651 | 11 792 |
| Staff expenses | — | — | — | — | — | — | — | — | −9 767 | −9 523 |
| EBITDA | — | −79 | 3 989 | −1 398 | −1 794 | −3 071 | −7 908 | −5 933 | −2 131 | −284 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −32 | −54 | −66 | −29 | −17 |
| EBIT | 0 | −79 | 3 989 | −1 398 | −1 794 | −3 103 | −7 962 | −5 999 | −2 160 | −300 |
| Net financials | — | — | −15 | −1 | −10 | −3 | −1 | −36 | −10 | −3 |
| Profit before tax | 0 | −79 | 2 999 | −424 | −1 804 | −3 106 | −7 963 | −6 035 | −2 170 | −303 |
| Tax | −0 | −0 | −644 | −0 | −0 | −0 | −0 | −0 | −101 | — |
| Net profit | 0 | −79 | 2 355 | −424 | −1 804 | −3 106 | −7 963 | −6 035 | −2 270 | −303 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 84 | 255 | 9 064 | 1 771 | 5 015 | 6 566 | 10 654 | 5 996 | 2 112 | 6 511 |
| Equity | 50 | 71 | 2 425 | 601 | 3 878 | 5 771 | 8 811 | 2 776 | 506 | 203 |
| Long-term debt | 19 | 119 | 19 | 19 | 39 | 67 | 9 | 9 | 0 | 2 909 |
| Short-term debt | 15 | 65 | 5 645 | 1 150 | 1 098 | 728 | 1 834 | 3 211 | 1 606 | 3 399 |
| Total debt | 34 | 184 | 5 664 | 1 169 | 1 137 | 795 | 1 843 | 3 220 | 1 606 | 6 309 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20152024
Equity ratio
3.1%
This company
38.2%
Market median
-92% vs market
20152024
Return on equity
-149.7%
This company
18.4%
Market median
-914% vs market
20152024
Net profit margin
-2.6%
This company
8.1%
Market median
-132% vs market
20152024
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
20152024
Debt / equity
31.15×
This company
0.62×
Market median
-4924% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PR Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
SD | Audit | 2022 | — | — |
ZM Audit | Audit | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BONEPROX AB 
Konekta ABBoard members of BONEPROX AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peder Remman | Chief Executive Officer | 0 companies |
| Sven David Tomas Näsfeldt | Audit | 0 companies |
| Zlatan Mitrovic | Audit | 0 companies |
| Carl Sebastian Christofer Schröder | Board of Directors | 0 companies |
| Banafsheh Susanne Najafi Amirkiasar | Board of Directors | 0 companies |
| Laszlo Janos Varga | Board of Directors | 0 companies |
| Anton Kjell Martin Kärrbrink | Chairman | 0 companies |
| Johan Jesper Kärrbrink | Board of Directors | 0 companies |
| Per Mikael Sverkerson Rehnberg | Board of Directors | 0 companies |
| Sara Kerstin Maria Resvik | Board of Directors | 0 companies |
| Pål Remman | Board of Directors | 0 companies |
| Viktor Karl Georg Sellman | Chairman | 0 companies |